May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Roberto ScicaliDepartment of Clinical and Experimental Medicine, University of Catania, ItalyAntonino Di PinoDepartment of Clinical and Experimental Medicine, University of Catania, ItalySalvatore PiroDepartment of Clinical and Experimental Medicine, University of Catania, ItalyAgata Maria RabuazzoDepartment of Clinical and Experimental Medicine, University of Catania, ItalyFrancesco PurrelloDepartment of Clinical and Experimental Medicine, University of Catania, Italy. Electronic address: [email protected]
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0